Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of The Role of Barrier Resection in Local Control in Treatment of Extremity Soft Tissue Sarcomas

NCT02120768 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02120768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02120768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of The Role of Barrier Resection in Local Control in Treatment of Extremity Soft Tissue Sarcomas
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2014
Completion date
December 31, 2018
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

local recurrence of malignant tumor of soft tissue